Cetera Investment Advisers Acquires 1,466 Shares of Zoetis Inc. $ZTS

Cetera Investment Advisers boosted its holdings in Zoetis Inc. (NYSE:ZTS) by 1.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 116,714 shares of the company’s stock after purchasing an additional 1,466 shares during the period. Cetera Investment Advisers’ holdings in Zoetis were worth $18,201,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Creative Planning lifted its stake in shares of Zoetis by 0.6% in the 2nd quarter. Creative Planning now owns 89,416 shares of the company’s stock valued at $13,944,000 after acquiring an additional 560 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in Zoetis by 6.6% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 109,190 shares of the company’s stock worth $17,028,000 after purchasing an additional 6,786 shares during the period. Advisors Capital Management LLC boosted its stake in shares of Zoetis by 5.7% during the second quarter. Advisors Capital Management LLC now owns 142,837 shares of the company’s stock valued at $22,276,000 after purchasing an additional 7,760 shares during the period. Burling Wealth Partners LLC grew its holdings in shares of Zoetis by 22.0% in the second quarter. Burling Wealth Partners LLC now owns 27,100 shares of the company’s stock worth $4,226,000 after purchasing an additional 4,880 shares during the last quarter. Finally, Hibernia Wealth Partners LLC bought a new position in shares of Zoetis in the second quarter worth approximately $264,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ZTS has been the subject of several analyst reports. Stifel Nicolaus dropped their price target on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research report on Tuesday. Argus reiterated a “buy” rating and set a $190.00 target price on shares of Zoetis in a report on Tuesday, September 9th. BTIG Research cut their target price on Zoetis from $200.00 to $160.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Morgan Stanley lowered their price target on Zoetis from $211.00 to $175.00 and set an “overweight” rating for the company in a research report on Monday, November 10th. Finally, UBS Group cut their price objective on Zoetis from $158.00 to $141.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Six equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $178.89.

Zoetis Trading Down 0.4%

Shares of ZTS opened at $118.30 on Wednesday. Zoetis Inc. has a 1-year low of $117.09 and a 1-year high of $181.85. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The firm’s 50-day moving average price is $139.63 and its 200-day moving average price is $150.90. The firm has a market capitalization of $52.13 billion, a price-to-earnings ratio of 20.36, a PEG ratio of 2.31 and a beta of 0.90.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. Zoetis’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.7%. Zoetis’s payout ratio is currently 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.